Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin

World Journal of Gastroenterology

Volumn 15, Issue 21, 2009, Pages 2628-2631

  Peralta, Sergio ^a   Cottone, Claudia ^a   Doveri, Tiziana ^a   Almasio, Piero Luigi ^a   Craxi, Antonio ^a  

^a DiBiMIS   (Italy)

Author keywords

Irritable bowel syndrome; Locally non absorbable antibiotics; Rifaximin; Small intestinal bacterial overgrowth

Indexed keywords

LACTULOSE; RIFAXIMIN;

ABDOMINAL DISCOMFORT; ABSENCE OF SIDE EFFECTS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL OVERGROWTH; BLOATING; BREATH ANALYSIS; CONSTIPATION; DIARRHEA; DRUG RESPONSE; FEMALE; HUMAN; IRRITABLE COLON; ITALY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREVALENCE; SMALL INTESTINE; SMALL INTESTINE BACTERIAL OVERGROWTH; SMALL INTESTINE DISEASE; SYMPTOM;

EID: 67651222067     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.2628     Document Type: Article

References (24)

1. Lin HC. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 2004; 292: 852-858
2. Cuoco L, Salvagnini M. Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with Rifaximin. Minerva Gastroenterol Dietol 2006; 52: 89-95
3. Majewski M, Reddymasu SC, Sostarich S, Foran P, McCallum RW. Efficacy of Rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth. Am J Med Sci 2007; 333: 266-270
4. King CE, Toskes PP. Breath tests in the diagnosis of small intestine bacterial overgrowth. Crit Rev Clin Lab Sci 1984; 21: 269-281
5. Ghoshal UC, Ghoshal U, Das K, Misra A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian J Gastroenterol 2006; 25: 6-10
6. Posserud I, Stotzer PO, Bjornsson ES, Abrahamsson H, Simren M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007; 56: 802-808
7. Pimentel M, Wallace D, Hallegua D, Chow E, Kong Y, Park S, Lin HC. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis 2004; 63: 450-452
8. Van Citters GW, Lin HC. Management of small intestinal bacterial overgrowth. Curr Gastroenterol Rep 2005; 7: 317-320
9. Walters B, Vanner SJ. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol 2005; 100: 1566-1570
10. Pimentel M, Kong Y, Park S. Breath testing to evaluate lactose intolerance in irritable bowel syndrome correlates with lactulose testing and may not reflect true lactose malabsorption. Am J Gastroenterol 2003; 98: 2700-2704
11. Karsenti D, Bechade D, Fallik D, Bili H, Desrame J, Coutant G, Algayres JP, Daly JP. [Small intestine bacterial overgrowth: six case reports and literature review] Rev Med Interne 2001; 22: 20-29
12. Bondarenko VM, Lykova EA, Matsulevich TV. [Microecological aspects of small intestinal bacterial overgrowth syndrome] Zh Mikrobiol Epidemiol Immunobiol 2006; 57-63
13. Bayeli PF, Mariottini M, Lisi L, Ferrari P, Tedone F. [Guidelines on intestinal dysmicrobism (SIBO Small Intestine Bacterial Overgrowth)] Minerva Gastroenterol Dietol 1999; 45: 297-308
14. Di Stefano M, Miceli E, Missanelli A, Corazza GR. Treatment of small intestine bacterial overgrowth. Eur Rev Med Pharmacol Sci 2005; 9: 217-222
15. Corazza GR, Sorge M, Strocchi A, Benati G, Di Sario A, Treggiari EA, Brusco G, Gasbarrini G. Non-absorbable antibiotics and small bowel bacterial overgrowth. Ital J Gastroenterol 1992; 24: 4-9
16. Polter DE, Boyle JD, Miller LG, Finegold SM. Anaerobic bacteria as cause of the blind loop syndrome. A case report with observations on response to antibacterial agents. Gastroenterology 1968; 54: 1148-1154
17. Lykova EA, Bondarenko VM, Parfenov AI, Matsulevich TV. [Bacterial overgrowth syndrome in the small intestine: pathogenesis, clinical significance and therapy tactics] Eksp Klin Gastroenterol 2005; 51-57, 113
18. Di Stefano M, Malservisi S, Veneto G, Ferrieri A, Corazza GR. Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2000; 14: 551-556
19. Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon. World J Gastroenterol 2005; 11: 2773-2776
20. Tursi A, Brandimarte G, Giorgetti G. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol 2003; 98: 839-843
21. Attar A, Flourie B, Rambaud JC, Franchisseur C, Ruszniewski P, Bouhnik Y. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology 1999; 117: 794-797
22. Castiglione F, Rispo A, Di Girolamo E, Cozzolino A, Manguso F, Grassia R, Mazzacca G. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease. Aliment Pharmacol Ther 2003; 18: 1107-1112
23. Bhatnagar S, Bhan MK, Sazawal S, Gupta U, George C, Arora NK, Kashyap DK. Efficacy of massive dose oral gentamicin therapy in nonbloody persistent diarrhea with associated malnutrition. J Pediatr Gastroenterol Nutr 1992; 15: 117-124
24. Knoke M, Bernhardt H, Mollmann R, Bootz T. [Therapeutic study of the effect of selective decontamination on microbial overgrowth syndrome of the small intestine] Gastroenterol J 1989; 49: 59-62